Abiopharma

🔍 Fleury Patrick (Executive)

Company: TERAWULF INC. (WULF)

Report Date: 2026-08-01

Detailed Transactions and Holdings:

• Acquired 500,000 shares of Common stock, $0.001 par value per share (Direct)
  Date: 2026-08-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 500,000.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common stock, $0.001 par value per share (Direct)
  Date: 2026-08-01 | Code: H | nature_of_ownership: By The Fleury-Reycroft Revocable Trust | shares_owned_after: 4,005,519.00 | Footnotes: F2
• Sold 500,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,000,000.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4, F4

Footnotes:

• F1: The Reporting Person received restricted stock units which vested in accordance with their terms upon the first anniversary of August 1, 2025, as reflected in this Form 4, subject to the Reporting Person's continued employment or service with the Issuer through such date.
• F2: By the Fleury-Reycroft Revocable Trust (the "Revocable Trust"). The Reporting Person contributed (i) 1 million of the Issuer's shares of common stock, par value $0.001 per share ("Common Stock") to the Revocable Trust on July 31, 2026, and (ii) 3,005,519 shares of Common Stock to the Revocable Trust on August 3, 2026, in each case for no consideration. The Reporting Person is serving as co-trustee of the Revocable Trust and may be deemed to have the power to direct the voting and disposition of the beneficially owned by the Revocable Trust. Accordingly, pursuant to the regulations promulgated under Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the Reporting Person may be deemed to be a beneficial owner of the shares of Common Stock held for the account of the Revocable Trust.
• F3: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's Common Stock.
• F4: The restricted stock units vested upon the first anniversary of August 1, 2025, subject to the Reporting Person's continued employment or service with the Issuer through such date. The remaining restricted stock units will vest ratably upon the second and third anniversaries of August 1, 2025, respectively, subject to the Reporting Person's continued employment or service with the Issuer through each such date.